European Union - English - EMA (European Medicines Agency)

clinuvel europe limited - afamelanotide - protoporphyria, erythropoietic - emollients and protectives - prevention of phototoxicity in adult patients with erythropoietic protoporphyria (epp).

Israel - English - Ministry of Health

dor pharmaceutical services ltd., israel - afamelanotide as acetate - implant - afamelanotide as acetate 16 mg - afamelanotide - scenesse is indicated for prevention of phototoxicity in adult patients with erythropoietic protoporphyria (epp).

Australia - English - Department of Health (Therapeutic Goods Administration)

clinuvel pharmaceuticals ltd - afamelanotide acetate, quantity: 18 mg - implant - excipient ingredients: polyglactin - scenesse is indicated for prevention of phototoxicity in adult patients with erythropoietic protoporphyria (epp)